• English
  • Eesti

    Main Activities of HMA

    05.06.2017
    Printer-friendly version

    The HMA:

    • addresses key strategic issues for the network, such as exchange of information, IT developments and sharing of best practices
    • focuses on the development, co-ordination and consistency of the European Medicines Regulatory System
    • ensures the most effective and efficient use of resources across the network. This includes developing and overseeing arrangements for work-sharing
    • co-ordinates the mutual recognition (MRP) and decentralised procedures (DCP).

    Member agencies support the network by providing high-quality professional and scientific resources to all areas of medicines regulation including centralised, MRP, DCP and national procedures.